Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.0B | 7B | 5.0B | 4.9B |
| Cost of revenue | 6.0B | 4.8B | 3.3B | 3.2B |
| Gross profit | 2.0B | 2.2B | 1.7B | 1.7B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | -6M | -240M | 2M | -61M |
| Operating income | 1.3B | 1.6B | 1.1B | 1.2B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 442M | 448M | 325M | 298M |
| Other income expense | 68M | 152M | 99M | 92M |
| Pretax income | 888M | 1.3B | 912M | 1.0B |
| Tax provision | 197M | 328M | 219M | 243M |
| Net income | 691M | 1B | 693M | 780M |
| Basic EPS | 1.0 | 1.6 | 1.2 | 1.3 |
| Diluted EPS | 1.0 | 1.6 | 1.2 | 1.3 |
| Basic average shares | 611.4M | 584.7M | 584.8M | 584.6M |
| Diluted average shares | 612.5M | 586.8M | 586.7M | 585.8M |
| EBITDA | 1.8B | 2.2B | 1.5B | 1.6B |
| Net income from continuing op. | 691M | 1B | 693M | 780M |
| Minority interests | -55M | — | — | — |
| Preferred stock dividends | — | — | — | — |